Krishna K. Gupta
Founder & Chairman @ Romulus Capital
Boston, United States
Krishna K. Gupta is a Series A investor at Romulus Capital in Boston focused on Software and Health Care. Krishna K. Gupta is the Chairman and CEO at Presto. He is also the Founder and CEO of REMUS Capital. He attended the Massachusetts Institute of Technology.
- Total investments:
- 32
- Last investment:
- Lead investor:
- 63%
Last updated:
For AI agents: llms.txt
Industries Krishna K. Gupta invests in
Stages Krishna K. Gupta invests in
Countries Krishna K. Gupta invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 8 (25%)
- Health Care 5 (16%)
- Internet 4 (13%)
- Artificial Intelligence 4 (13%)
- Therapeutics 3 (9%)
Stage
- Series A 7 (22%)
- Seed 6 (19%)
- Funding Round 5 (16%)
- Series B 4 (13%)
- Series C 4 (13%)
Country
- United States 14 (44%)
- India 1 (3%)
- United Kingdom 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Presto overlays next-gen digital solutions onto the physical world. Presto’s enterprise-grade voice, vision, and touch technologies help hospitality businesses thrive while delighting guests. With over 250,000 systems shipped, Presto is one of the largest labor automation technology providers in the industry. Founded at M.I.T. in 2008, Presto isheadquartered in Silicon Valley, Calif. with customers including many of the top 20 restaurant chains in the U.S. | $18M / Jan 16, 2025 | ||
| Ceres AI s a SaaS-based aerial spectral imagery and analytics company that serves farmers and agribusinesses. Using proprietary sensors, analytics, machine learning models, and plant science, Ceres delivers university-validated imagery-based intelligence to farms in the US, Australia and South America. This enables customers to identify pest,disease, water, and fertilizer issues weeks before they are visible to the naked eye. | Series D / Sep 04, 2024 | ||
| Presto overlays next-gen digital solutions onto the physical world. Presto’s enterprise-grade voice, vision, and touch technologies help hospitality businesses thrive while delighting guests. With over 250,000 systems shipped, Presto is one of the largest labor automation technology providers in the industry. Founded at M.I.T. in 2008, Presto isheadquartered in Silicon Valley, Calif. with customers including many of the top 20 restaurant chains in the U.S. | $70M / Post-IPO Equity / Sep 21, 2022 | ||
| Spotta is the creator of an ultra-low-power insect monitoring sensor for detecting bed bug infestations. The company's sensor is battery-powered, allowing users to be notified whenever bed bugs are detected and analyzing the detection to ensure users are only notified about genuine incidents, allowing customers to prevent bed bugs fromentering the room and make treatment easier and less expensive. | $1.2M / Seed / Jul 28, 2020 | ||
| Allurion Technologies is developing a medical device for weight loss that can be delivered and removed without surgery or endoscopy. | $34M / Jan 07, 2020 | ||
| Cogito is a computer service company that enhances the emotional intelligence of phone professionals by applying behavioral science through artificial intelligence and machine learning. Its software evaluates hundreds of behavioral signals through voice to provide live conversation coaching for agents and a real-time measure of customer experiencefor every call. | $20M / Series C / Sep 05, 2019 | ||
| Vyome Biosciences is an innovation driven company, with a vision to develop novel drugs for antibiotics-resistant acne and other opportunist pathogens through a unique pipeline of antibiotics that retard resistance development. Vyome Biosciences’ management team members are the leaders in the field, with deep expertise, demonstratedcapability and a proven track record of successfully launching over 50 products in dermatology & other life sciences areas, and building visionary companies. Vyome’s development platform is completely risk mitigated. Vyome has a deep pipeline of IP based products targeting multiple indications. The *lead molecule (VB 1953)*, which targets the huge unmet need in the drug resistant acne prescription market, will be entering the clinical phase with *USFDA IND Application Filing in Q4 2015*. Vyome has state-of-the-art infrastructure facilities to carry out all its research and lab development work, with full-fledged formulation, analytical, chemistry, biology & molecular biology, clinical and the regulatory divisions. The infrastructure and the team enables Vyome to conceive ideas, develop them and commercialize them at a rapid pace. | $17.9M / Series D / Jan 03, 2019 | ||
| Ceres AI s a SaaS-based aerial spectral imagery and analytics company that serves farmers and agribusinesses. Using proprietary sensors, analytics, machine learning models, and plant science, Ceres delivers university-validated imagery-based intelligence to farms in the US, Australia and South America. This enables customers to identify pest,disease, water, and fertilizer issues weeks before they are visible to the naked eye. | $25M / Series B / Jun 28, 2018 | ||
| Zerocrater is a platform for office catering and snacks that allows users to select from a number of food options and have them delivered to their workplace from eateries. The platform of the company provides catering meals to small and medium-sized enterprises and simplifies the ordering procedure, allowing clients to create a high-performingoffice culture by bringing employees together over food.Zerocrater was established in 2009 in San Francisco, California by Arram Sabeti. | $12M / Series B / May 01, 2018 | ||
| Ceres AI s a SaaS-based aerial spectral imagery and analytics company that serves farmers and agribusinesses. Using proprietary sensors, analytics, machine learning models, and plant science, Ceres delivers university-validated imagery-based intelligence to farms in the US, Australia and South America. This enables customers to identify pest,disease, water, and fertilizer issues weeks before they are visible to the naked eye. | $2.5M / Series A / Nov 01, 2017 | ||
| See all 32 investments → | |||
Co-Investors
About Romulus Capital
Romulus Capital invests in early-stage technology companies that are looking to become industry leaders. We invest between $100K-$1M in brilliant – often first-time – entrepreneurs who are frequently affiliated with top universities and incubators. As a given company grows, our total investment can scale to $5M+ over time. We are focused oncompany-building, rather than betting, and we remain strong partners throughout the trajectory of growth. Our firm is young, entrepreneurial, and established, with a powerful investor base from around the world. We are a venture capital firm of the future, one that merges the classic, humanist focus on building large, impactful entities with the exciting realities of modern entrepreneurs.
Romulus Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Wysopal
Advisor
|
|||
Huck Jun Hong
Investor
|
|||
Ivan Dewerpe
Associate
|
|||
Neil Chheda
Co-founder and Managing Partner
|
|||
Rayyan Islam
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Krishna K. Gupta invest in?
Krishna K. Gupta invests primarily in Software, Health Care and Internet startups, most often at Series A and Seed stage. Most of the 32 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Krishna K. Gupta?
Public channels for Krishna K. Gupta include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Krishna K. Gupta last invest?
The most recent investment recorded for Krishna K. Gupta closed in Jan 2025. Shizune tracks 32 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
